Abbott Laboratories: Strong Q4 Results And Bullish Outlook
Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...
health.economictimes.indiatimes11d
Abbott launches Navitor Vision Valve to advance treatment of Aortic Stenosis
The Navitor Vision, Abbott's latest TAVI system, is designed to improve accuracy during implantation and enhance visibility ...
2 Unstoppable Dividend Stocks That Will Pay You for Life
In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As ...
Pharmabiz9d
Abbott introduces Navitor Vision in India, the next generation of heart valve technology designed to treat aortic stenosis
Our Bureau, Mumbai Thursday, January 30, 2025, 15:15 Hrs [IST] ...